JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

A Multi-Center, Double-Blind, Randomized, Comparator Controlled Trial Evaluating Topical Formulations for Skin Fragility of the Arms

Published online October 9, 2024

Dermatoporosis was the term coined by Kaya and Saurat in 2007 to describe fragile aging skin. The condition varies from simple skin thi...

read more
Cost Analysis of Sunscreens Targeted Towards Skin of Color

Published online October 2, 2024

Skin cancer is the most common cancer diagnosis and there are several preventative measures aimed at reducing its prevalence such as ph...

read more
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis

Published online September 30, 2024

Acne is a chronic dermatologic condition affecting up to 50 million people in the United States annually. 1 Although acne afflicts bot...

read more
Primary Hyperhidrosis and Sensitive Skin: Exploring the Link with Predictive Machine Learning-Based Classification Models

Published online September 30, 2024

Primary hyperhidrosis (PHH) is the most common disease of the eccrine gland, and is characterized by excessive sweating due to elevate...

read more
A Novel Protection and Repair Skincare Regimen Shows Efficacy for Improving Environmental Skin Aging

Published online September 30, 2024

The skin is the most exposed organ to the environment. Solar radiation, pollutants, and fluctuations in temperature are all environment...

read more
A Consensus on Staphylococcus Aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment

Published online September 30, 2024

Current Clinical Challenges in Atopic Dermatitis Management and Treatment Despite advances in topical and systemic treatment options...

read more
Application Characteristics and Patient Preference of Triple-Combination vs Layered Topicals for Acne: Split-Face Study

Published online September 25, 2024

In the treatment of acne, therapies that address multiple pathophysiological pathways are recommended for most patients. 1 Combination...

read more
Hypochlorous Acid: A Blast from the Past

Published online September 24, 2024

Hypochlorous acid (HOCl) is one of the latest skincare ingredients to gain widespread popularity on social media. Despite newfound int...

read more
A Review of the Vitiligo Literature to Standardize Expression of Disease Severity

Published online September 20, 2024

There is a poor understanding at this time as to best- practice in recording outcomes in vitiligo. This is because there is an extremel...

read more
Reply to “The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers”

Published online September 19, 2024

We read with great interest the Cartwright et al paper "The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Ski...

read more
Opt for Methotrexate Before Biologics in the Treatment of Recalcitrant Delayed-Onset Reactions To Dermal Fillers

Published online September 19, 2024

To the Editor: We read with interest the case of a post-hyaluronic acid (HA) filler reaction treated with abrocitinib, a JAK inhibitor (JAKi)...

read more
Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

Published online September 17, 2024

Atopic dermatitis (AD) is one of the most prevalent inflammatory skin conditions, characterized by recurrent eczema with varying degree...

read more
Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

Published online September 17, 2024

The role of the vehicle in topical prescription treatments is to deliver therapeutic concentrations of an active drug to a designated s...

read more
The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors

Published online September 16, 2024

Since the release of the first FDA-approved targeted biologic agent in 2017, several years have elapsed since a new systemic therapy ha...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

| Atopic Dermatitis, Dermatology Roundup, JDD Highlights, JDD in the Media, The Latest | No Comments
By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…

New Innovation for Addressing Hyperpigmentation in Diverse Patients

| JDD Highlights, JDD Webinars, The Latest | No Comments
Join Andrew Alexis, MD and Hawasatu Dumbuya, PhD, for an informative and interactive webinar on pigmentary disorders: unveiling insights on epidemiology, stigmatization, clinical perspectives, and a breakthrough innovation for hyperpigmentation.…

Formulation Foundations: A Peak Behind the Development Curtain

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. David Osborne Finding the right formulation is not always a fun endeavor for the practitioner or patient, and can be the make or break for patient…
The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas picture collection for drug reaction with eosinophilia and systemic symptoms, showcasing the condition in side by side multiple skin tones. Images and pictures of DRESS. Dermal, inflammatory, eosinophilic dermatology skin condition. Inclusive Derm Atlas, diversity in skin types. Skin of color included.

Decoding Derm: What’s the Diagnosis

| Inclusive Dermatology Atlas, JDD Highlights, The Latest, Video Pearls | No Comments
Join Dr. Alexis Carrington in Decoding Dermatology: What's the Diagnosis, as she presents a curated image collection from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. This selection…
Journal of Drugs in Dermatology JDD Article About Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

Assessing Patient Preferences for Atopic Dermatitis Treatment: A Review Article of Discrete Choice Experiments

| Featured Articles, The Latest | No Comments
JDD Article Highlights Struggling with treatment adherence in your atopic dermatitis (AD) patients? AD is a widespread inflammatory skin condition, but even with various treatment options, poor adherence - especially to…

Technology Innovations in Skincare from Neutrogena

| JDD Highlights, JDD Webinars, The Latest | No Comments
Join us for a panel discussion on innovations in the technology and formulation of essential skincare from Neutrogena. Dr Ted Lain and Dr Cheri Frey will be joined by Kenvue…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Wondering about Words: Evidence Based Framing for Improving Treatment Adherence

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Hosts: Dr. Adam Friedman and Dr. Steven Feldman Actions speak louder than words…so long as the words inspire, encourage, engage, etc. the actions. This altered adage rings…
Tune In

New CME Activities

Prevention is the Best Medicine: ADing up the Data

| Atopic Dermatitis, CME Activities, Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Candrice Heath, Dr. Jonathan O’B. Hourihane & Dr. Adam Friedman Continue to CME Activity Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for…
Explore CME

Follow Us